– Women with BRCA1/2 mutations face significantly elevated lifetime risks of ovarian cancer.
– Bilateral salpingo-oophorectomy (BSO) reduces ovarian cancer risk but the optimal timing varies by mutation type.
– Early BSO is strongly recommended (age 35 for BRCA1, 45 for BRCA2), yet some women delay surgery, increasing residual risk.
– Even at older ages, residual ovarian cancer risk remains sufficiently high to support consideration of preventive BSO in healthy women.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
